Wrapping up Cycle 2 and an upcoming event

Tomorrow I’ll be getting another dose of Eribulin, which will wrap up cycle 2. I will have one more cycle before getting scans. As blood work and liver pain has improved, I am fairly confident that the scans will show improvement in my liver as well. I’m not out of the woods just yet, but things are on the right track. Just gotta cross my fingers that the LMD has remained stable during all of this.

After scans, I plan on asking my team if I can try again with qualifying for the clinical trial that I want to participate in. That’s always been my goal! Just as an FYI, the clinical trial I want to participate in would put me back on a drug categorized as an antibody drug conjugate (ADC). I have been on two ADCs (Enhertu and Todelvy/Saci) in the last year. Although I haven’t been an exceptional responder to these drugs, I have gotten an average time on them and have tolerated them fairly well, especially the Saci. The paper I recently had published emphasized the importance of studying and understanding the patient’s experience and why research needs to continue.

Speaking of which, my desire to participate in research/clinical trials has led me to being asked to participate in an upcoming event. I was asked to be a patient voice for a panel that will do a “flash” ask for donations for MBC research, specifically targeted at ADC research. My perspective as a patient that has experience with these drugs will hopefully bring a personal connection to research and hope for the future, and ultimately some large donations in for funding this research.

I will come back soon and report how the event went. XO